Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.840
0.00 (-0.02%)
At close: Jul 19, 2024, 4:00 PM
0.780
-0.060 (-7.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 4.25, with a low estimate of 2.50 and a high estimate of 7.50. The average target predicts an increase of 406.07% from the current stock price of 0.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 6, 2024.
Analyst Ratings
The average analyst rating for LUCD stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 1 | 1 | 1 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $7.5 | Strong Buy | Maintains | $8 → $7.5 | +793.07% | Jun 6, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | +257.23% | May 15, 2024 |
Needham | Needham | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +197.69% | May 13, 2024 |
Needham | Needham | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +197.69% | Apr 12, 2024 |
Needham | Needham | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +197.69% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
5.65M
from 2.43M
Increased by 132.78%
Revenue Next Year
15.82M
from 5.65M
Increased by 179.95%
EPS This Year
-1.11
from -1.26
EPS Next Year
-0.74
from -1.11
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.1M | 38.3M | 94.3M | 141.4M | 176.8M |
Avg | 5.7M | 15.8M | 52.4M | 85.8M | 112.2M |
Low | 4.5M | 6.9M | 17.3M | 32.8M | 50.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 234.8% | 577.5% | 495.9% | 170.1% | 106.1% |
Avg | 132.8% | 180.0% | 230.9% | 63.8% | 30.8% |
Low | 85.7% | 21.3% | 9.6% | -37.3% | -41.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.11 | -0.59 | 0.13 | -0.58 | -0.46 |
Avg | -1.11 | -0.74 | -0.32 | -0.56 | -0.45 |
Low | -1.10 | -0.82 | -0.73 | -0.54 | -0.43 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.